142 related articles for article (PubMed ID: 10509877)
1. Thermal, but not mechanical, nociceptive behavior is altered in the Zucker Diabetic Fatty rat and is independent of glycemic status.
Piercy V; Banner SE; Bhattacharyya A; Parsons AA; Sanger GJ; Smith SA; Bingham S
J Diabetes Complications; 1999; 13(3):163-9. PubMed ID: 10509877
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Smith SA; Lister CA; Toseland CD; Buckingham RE
Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.
Griggs RB; Donahue RR; Adkins BG; Anderson KL; Thibault O; Taylor BK
J Pain; 2016 Mar; 17(3):359-73. PubMed ID: 26687453
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
[TBL] [Abstract][Full Text] [Related]
5. A Correlative Relationship Between Chronic Pain and Insulin Resistance in Zucker Fatty Rats: Role of Downregulation of Insulin Receptors.
Zhai X; Sun C; Rong P; Li S; McCabe MF; Wang X; Mao J; Wang S
J Pain; 2016 Apr; 17(4):404-13. PubMed ID: 26705975
[TBL] [Abstract][Full Text] [Related]
6. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
8. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
9. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
10. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
Pickavance L; Widdowson PS; King P; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
[TBL] [Abstract][Full Text] [Related]
11. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
MacDonald MJ; Tang J; Polonsky KS
Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.
Lu X; Guo X; Karathanasis SK; Zimmerman KM; Onyia JE; Peterson RG; Kassab GS
Cardiovasc Diabetol; 2010 May; 9():19. PubMed ID: 20482873
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.
Yue TL; Bao W; Gu JL; Cui J; Tao L; Ma XL; Ohlstein EH; Jucker BM
Diabetes; 2005 Feb; 54(2):554-62. PubMed ID: 15677515
[TBL] [Abstract][Full Text] [Related]
14. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.
Sugimoto K; Rashid IB; Kojima K; Shoji M; Tanabe J; Tamasawa N; Suda T; Yasujima M
Diabetes Metab Res Rev; 2008; 24(8):642-50. PubMed ID: 18973207
[TBL] [Abstract][Full Text] [Related]
15. Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats.
Garcia-Perez E; Schönberger T; Sumalla M; Stierstorfer B; Solà R; Doods H; Serra J; Gorodetskaya N
Eur J Pain; 2018 Sep; 22(8):1457-1472. PubMed ID: 29676840
[TBL] [Abstract][Full Text] [Related]
16. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
17. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
[TBL] [Abstract][Full Text] [Related]
18. Pressure pain precedes development of type 2 disease in Zucker rat model of diabetes.
Romanovsky D; Walker JC; Dobretsov M
Neurosci Lett; 2008 Nov; 445(3):220-3. PubMed ID: 18790004
[TBL] [Abstract][Full Text] [Related]
19. Appropriateness of the Zucker Diabetic Fatty rat as a model for diabetic microvascular late complications.
Hempe J; Elvert R; Schmidts HL; Kramer W; Herling AW
Lab Anim; 2012 Jan; 46(1):32-9. PubMed ID: 22087029
[TBL] [Abstract][Full Text] [Related]
20. Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.
Resch M; Schmid P; Amann K; Fredersdorf S; Weil J; Schach C; Birner C; Griese DP; Kreuzer P; Brunner S; Luchner A; Riegger GA; Endemann DH
Cardiovasc Diabetol; 2011 Oct; 10():94. PubMed ID: 22008236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
